These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12717427)

  • 21. Reactivation of SYK expression by inhibition of DNA methylation suppresses breast cancer cell invasiveness.
    Yuan Y; Liu H; Sahin A; Dai JL
    Int J Cancer; 2005 Feb; 113(4):654-9. PubMed ID: 15455373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic studies of the spleen protein tyrosine kinase locus reveal a complex promoter structure and several genetic variants.
    Goodman PA; Jurana B; Wood CM; Uckun F
    Leuk Lymphoma; 2002 Aug; 43(8):1627-35. PubMed ID: 12400606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylation level of CpG islands in GGH gene promoter in pediatric acute leukemia.
    Li Y; Liu S; Wang H; Mai H; Yuan X; Li C; Chen X; Wen F
    PLoS One; 2017; 12(3):e0173472. PubMed ID: 28278270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promoter methylation-mediated inactivation of PCDH10 in acute lymphoblastic leukemia contributes to chemotherapy resistance.
    Narayan G; Freddy AJ; Xie D; Liyanage H; Clark L; Kisselev S; Un Kang J; Nandula SV; McGuinn C; Subramaniyam S; Alobeid B; Satwani P; Savage D; Bhagat G; Murty VV
    Genes Chromosomes Cancer; 2011 Dec; 50(12):1043-53. PubMed ID: 21960365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
    Kunze E; Wendt M; Schlott T
    Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The dioxin receptor is silenced by promoter hypermethylation in human acute lymphoblastic leukemia through inhibition of Sp1 binding.
    Mulero-Navarro S; Carvajal-Gonzalez JM; Herranz M; Ballestar E; Fraga MF; Ropero S; Esteller M; Fernandez-Salguero PM
    Carcinogenesis; 2006 May; 27(5):1099-104. PubMed ID: 16410262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma.
    Agrelo R; Setien F; Espada J; Artiga MJ; Rodriguez M; Pérez-Rosado A; Sanchez-Aguilera A; Fraga MF; Piris MA; Esteller M
    J Clin Oncol; 2005 Jun; 23(17):3940-7. PubMed ID: 15867203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic and HIF-1 regulation of stanniocalcin-2 expression in human cancer cells.
    Law AY; Lai KP; Ip CK; Wong AS; Wagner GF; Wong CK
    Exp Cell Res; 2008 May; 314(8):1823-30. PubMed ID: 18394600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. E-cadherin expression is silenced by 5' CpG island methylation in acute leukemia.
    Corn PG; Smith BD; Ruckdeschel ES; Douglas D; Baylin SB; Herman JG
    Clin Cancer Res; 2000 Nov; 6(11):4243-8. PubMed ID: 11106238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Abnormal methylation of p16/CDKN2A AND p14/ARF genes GpG Islands in non-small cell lung cancer and in acute lymphoblastic leukemia].
    Zemliakova VV; Strel'nikov VV; Zborovskaia IB; Balukova OV; Maĭorova OA; Vasil'ev EV; Zaletaev DV; Nemtsova MV
    Mol Biol (Mosk); 2004; 38(6):966-72. PubMed ID: 15612580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spleen tyrosine kinase as a novel candidate tumor suppressor gene for human oral squamous cell carcinoma.
    Ogane S; Onda T; Takano N; Yajima T; Uchiyama T; Shibahara T
    Int J Cancer; 2009 Jun; 124(11):2651-7. PubMed ID: 19195024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential regulation of human T-plastin gene in leukocytes and non-leukocytes: identification of the promoter, enhancer, and CpG island.
    Lin CS; Lau A; Huynh T; Lue TF
    DNA Cell Biol; 1999 Jan; 18(1):27-37. PubMed ID: 10025506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequent epigenetic inactivation of spleen tyrosine kinase gene in human hepatocellular carcinoma.
    Yuan Y; Wang J; Li J; Wang L; Li M; Yang Z; Zhang C; Dai JL
    Clin Cancer Res; 2006 Nov; 12(22):6687-95. PubMed ID: 17121887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of spleen tyrosine kinase in hepatocellular carcinoma by promoter CpG island hypermethylation and its potential role in carcinogenesis.
    Shin SH; Lee KH; Kim BH; Lee S; Lee HS; Jang JJ; Kang GH
    Lab Invest; 2014 Dec; 94(12):1396-405. PubMed ID: 25310533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promoter hypermethylation-mediated inactivation of LRRC4 in gliomas.
    Zhang Z; Li D; Wu M; Xiang B; Wang L; Zhou M; Chen P; Li X; Shen S; Li G
    BMC Mol Biol; 2008 Nov; 9():99. PubMed ID: 18976507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequent epigenetic inactivation of the SLIT2 gene in chronic and acute lymphocytic leukemia.
    Dunwell TL; Dickinson RE; Stankovic T; Dallol A; Weston V; Austen B; Catchpoole D; Maher ER; Latif F
    Epigenetics; 2009 May; 4(4):265-9. PubMed ID: 19550140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic potential of spleen tyrosine kinase inhibition for treating high-risk precursor B cell acute lymphoblastic leukemia.
    Perova T; Grandal I; Nutter LM; Papp E; Matei IR; Beyene J; Kowalski PE; Hitzler JK; Minden MD; Guidos CJ; Danska JS
    Sci Transl Med; 2014 May; 6(236):236ra62. PubMed ID: 24828076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression and Promoter CpG Island Methylation Status of miR-34b in Leukemia Cell Lines and Their Clinical Significance].
    Guo JX; Zhou YH; Guan RT; Pan JX; Zhang XY; Zhong JF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1235-9. PubMed ID: 26524015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Quantitative microarray-based DNA methylation analysis of E-cadherin gene promoter in acute leukemia].
    Chen BA; Zhang F; Wang Y; Zheng WL; Du J; Gao C; Ding JH; Sun YY; Cheng J; Wang J; Zhao G; Chen NN; Lu ZH
    Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):41-4. PubMed ID: 17575692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic changes in the DAP-kinase CpG island in pediatric lymphoma.
    Shiramizu B; Mick P
    Med Pediatr Oncol; 2003 Dec; 41(6):527-31. PubMed ID: 14595709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.